Optic Neuritis Terminated Phase 2 Trials for Atacicept (DB06399)

Also known as: Optical Neuritis / Unspecified optic neuritis / Optic neuritis NOS / Optic neuritis, unspecified / Neuritis optic

IndicationStatusPhase
DBCOND0027863 (Optic Neuritis)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00624468Atacicept in Subjects With Optic NeuritisTreatment